Skip to main content
The Punxsutawney Spirit
Place an Ad
Classified Display Ads
Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
New York Composite
Drug Manufacturers - Major Sector
Streaming Delayed Price
11:07 AM EDT, Sep 25, 2018
Add to My Watchlist
Price and Volume
2049.14 - 2063.26
1735.78 - 2062.40
Johnson & Johnson
Spectrum Pharma Inc
USMV, PFE, WM, ACN: Large Inflows Detected at ETF
Today 10:59 EDT
Symbols mentioned in this story: USMV, PFE, WM, ACN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Melinda Gates calls on Corporate America to provide paid parental leave for new dads and moms
Today 10:59 EDT
The workplace today is not designed for families, and that needs to change, philanthropist Melinda Gates says.
Eli Lilly & Co Crosses Above its 10-day MA (LLY)
Today 10:32 EDT
Eli Lilly & Co (NYSE:LLY) shares have crossed bullishly above their 10-day moving average of $106.10 on a volume of 636K shares. This may provide swing traders with an...
Comtex SmarTrend® News Briefs
Elanco Animal Health IPO
Today 9:29 EDT
Listener Evan is interested in the Eli Lilly spinout, which went public last Thursday.
Sanofi US Named to Working Mother 2018 "100 Best Companies" List
Today 9:00 EDT
Working Mother has named Sanofi US as one of the top 100 companies for working mothers. The 2018 Working Mother "100 Best Company" list celebrates companies that lead in the areas of female career...
Factors of Influence in 2018, Key Indicators and Opportunity within Dorchester Minerals, Teladoc, Pfizer, Intercontinental Exchange, General Electric, and Prospect Capital — New Research Emphasizes Ec
Today 8:50 EDT
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Dorchester Minerals, L.P....
GlobeNewswire News Releases
The Daily Biotech Pulse: Syndax Lung Cancer Trial Disappoints, Gemphire To Trim Workforce, Opiant's Offering
Today 8:30 EDT
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting ...
IMFINZI® (durvalumab) is the First Immunotherapy to Demonstrate Significant Overall Survival Benefit in Unresectable, Stage III Lung Cancer
Today 8:22 EDT
AstraZeneca and MedImmune, its global biologics research and development arm, have presented data on overall survival (OS) in the Phase III PACIFIC trial of IMFINZI® (durvalumab) during the...
Business Wire News Releases
Data & News supplied by
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Terms and Conditions
Copyright © 2015 The Punxsutawney Spirit | 510 Pine Street | Punxsutawney, PA 15767 | 814-938-8740
All property rights for the entire contents of this publication shall be the property of The Punxsutawney Spirit.
No part hereof may be reproduced without prior written consent.